Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464295
Status:
COMPLETED
Last Update Posted:
2007-12-14
First Post:
2007-04-20
Brief Title:
Phase II Trial of Capecitabine for the Treatment of Unresectable Metastatic or Advanced Hepatocellular CarcinomaHCC
Sponsor:
Aga Khan University
Organization:
Aga Khan University
Organization Data
Organization:
Aga Khan University
Class:
OTHER
Study ID:
449-MedERC-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Aga Khan University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Muhammad Kashif Anis
Old Organization:
Aga Khan University